Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Net Cash Flow (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Net Cash Flow for 16 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Cash Flow rose 136.97% year-over-year to $1.1 million, compared with a TTM value of $1.3 million through Sep 2025, down 72.22%, and an annual FY2024 reading of $6.7 million, up 699.46% over the prior year.
  • Net Cash Flow was $1.1 million for Q3 2025 at Rockwell Medical, up from $1.1 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $20.9 million in Q2 2022 and bottomed at -$17.8 million in Q3 2022.
  • Average Net Cash Flow over 5 years is -$1.8 million, with a median of -$1.9 million recorded in 2023.
  • The sharpest move saw Net Cash Flow soared 732.94% in 2022, then plummeted 394.47% in 2024.
  • Year by year, Net Cash Flow stood at -$10.1 million in 2021, then soared by 71.53% to -$2.9 million in 2022, then surged by 142.49% to $1.2 million in 2023, then skyrocketed by 171.87% to $3.3 million in 2024, then crashed by 66.08% to $1.1 million in 2025.
  • Business Quant data shows Net Cash Flow for RMTI at $1.1 million in Q3 2025, $1.1 million in Q2 2025, and -$4.3 million in Q1 2025.